Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Sarepta |
Description | SAREPTA IS COMMITTED TO THE ADVANCEMENT OF SAREPTA IS COMMITTED TO THE ADVANCEMENT OF THERAPY Three FDA-approved treatments now available. For Patients and Caregivers For HEALTH CARE PROFESSIONALS |
Keywords | N/A |
WebSite | sareptadmd.com |
Host IP | 54.204.43.126 |
Location | United States |
Site | Rank |
US$450,166
Last updated: 2023-05-17 19:02:34
sareptadmd.com has Semrush global rank of 23,512,018. sareptadmd.com has an estimated worth of US$ 450,166, based on its estimated Ads revenue. sareptadmd.com receives approximately 51,943 unique visitors each day. Its web server is located in United States, with IP address 54.204.43.126. According to SiteAdvisor, sareptadmd.com is safe to visit. |
Purchase/Sale Value | US$450,166 |
Daily Ads Revenue | US$416 |
Monthly Ads Revenue | US$12,467 |
Yearly Ads Revenue | US$149,594 |
Daily Unique Visitors | 3,463 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
sareptadmd.com. | A | 3599 | IP: 54.204.43.126 |
sareptadmd.com. | NS | 3600 | NS Record: dns1.easydns.com. |
sareptadmd.com. | NS | 3600 | NS Record: dns3.easydns.org. |
sareptadmd.com. | NS | 3600 | NS Record: dns4.easydns.info. |
sareptadmd.com. | NS | 3600 | NS Record: dns2.easydns.net. |
sareptadmd.com. | MX | 3600 | MX Record: 0 mx-caprica.easydns.com. |
sareptadmd.com. | TXT | 3600 | TXT Record: google-site-verification=gYrZzuk8Cvs0hod0RIuarNR-3MsRZWDdihyvI1rTD2s |
SAREPTA IS COMMITTED TO THE ADVANCEMENT OF THERAPY Three FDA-approved treatments now available. For Patients and Caregivers For HEALTH CARE PROFESSIONALS Prescribing Information EXONDYS 51 injection is supplied in single-dose vials containing 100 mg/2 mL (50 mg/mL) eteplirsen or 500 mg/10 mL (50 mg/mL) eteplirsen. Visit the EXONDYS 51 site for more information. WHAT IS EXONDYS 51 (eteplirsen)? EXONDYS 51 is used to treat Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation in the dystrophin gene that can be treated by skipping exon 51. EXONDYS 51 was approved under accelerated approval. Accelerated approval allows for drugs to be approved based on a marker that is considered reasonably likely to predict a clinical benefit. EXONDYS 51 treatment increased the marker, dystrophin, in skeletal muscle in some patients. Verification of a clinical benefit may be needed for EXONDYS 51 to continue to be approved. IMPORTANT RISK INFORMATION FOR EXONDYS 51 Allergic |
HTTP/1.1 301 Moved Permanently Server: nginx Date: Wed, 13 Apr 2022 09:36:49 GMT Content-Type: text/html; charset=iso-8859-1 Content-Length: 231 X-Content-Type-Options: nosniff Location: https://sareptadmd.com/ Cache-Control: max-age=1209600 Expires: Wed, 27 Apr 2022 09:36:49 GMT X-Request-ID: v-3e11f6a8-bb0d-11ec-b9a4-bb8deac59b5a Age: 85300 Via: varnish X-Cache: HIT X-Cache-Hits: 40 Connection: keep-alive HTTP/2 200 server: nginx date: Thu, 14 Apr 2022 09:18:30 GMT content-type: text/html content-length: 13432 x-content-type-options: nosniff vary: Host,Accept-Encoding last-modified: Mon, 06 Dec 2021 17:05:13 GMT cache-control: max-age=1209600 expires: Wed, 27 Apr 2022 08:16:11 GMT x-request-id: v-fabdf448-bb01-11ec-a7d5-4f1266c0823e x-ah-environment: prod age: 90138 via: varnish x-cache: HIT x-cache-hits: 50 accept-ranges: bytes |
Domain Name: SAREPTADMD.COM Registry Domain ID: 2545036937_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2021-07-06T05:16:48Z Creation Date: 2020-07-10T12:03:27Z Registry Expiry Date: 2022-07-10T12:03:27Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DNS1.EASYDNS.COM Name Server: DNS2.EASYDNS.NET Name Server: DNS3.EASYDNS.ORG Name Server: DNS4.EASYDNS.INFO DNSSEC: unsigned >>> Last update of whois database: 2022-04-14T09:44:44Z <<< |